Cargando…

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians

IMPORTANCE: Transparency of industry payments to physicians could engender greater public trust in physicians but might also lead to greater mistrust of physicians and the medical profession, adversely affecting the patient-physician relationship. OBJECTIVE: To examine the association between nation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanter, Genevieve P., Carpenter, Daniel, Lehmann, Lisa S., Mello, Michelle M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481437/ https://www.ncbi.nlm.nih.gov/pubmed/30977850 http://dx.doi.org/10.1001/jamanetworkopen.2019.1947

Ejemplares similares

Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment
por: Kanter, Genevieve P, et al.
Publicado: (2019)

Impact of US industry payment disclosure laws on payments to surgeons: a natural experiment
por: Rhee, Taeho Greg, et al.
Publicado: (2020)

Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
por: Hartung, Daniel M., et al.
Publicado: (2018)

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021
por: Singh, Armaan, et al.
Publicado: (2022)

Barriers to Disclosure of Disability and Request for Accommodations Among First-Year Resident Physicians in the US
por: Pereira-Lima, Karina, et al.
Publicado: (2023)

Contemporary Analysis of Inconsistencies Between Physician-reported Disclosures at the AAOS Annual Meeting and Industry-reported Financial Disclosures in the Open Payments Database
por: Bovonratwet, Patawut, et al.
Publicado: (2022)

Trends in Industry Payments to Physicians in the First 6 Years After Graduate Medical Training
por: Han, Misop, et al.
Publicado: (2022)

Public perceptions of physician-pharmaceutical industry relationships and trust in physicians
por: Saito, Sayaka, et al.
Publicado: (2023)

Association Between Open Payments–Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US
por: Nguyen, Andrew M., et al.
Publicado: (2022)

Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study
por: Norris, Susan L, et al.
Publicado: (2012)

Industry Payments Received by Residents During Training
por: Hogan, Sean O., et al.
Publicado: (2023)

Industry payments to physician journal editors
por: Wong, Victoria S. S., et al.
Publicado: (2019)

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Association of Physician Group Participation in Accountable Care Organizations With Patient Social and Clinical Characteristics
por: Werner, Rachel M., et al.
Publicado: (2019)

Public Perceptions of Physician Attire and Professionalism in the US
por: Xun, Helen, et al.
Publicado: (2021)

Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
por: Saito, Hiroaki, et al.
Publicado: (2019)

US Growth Hormone Use in the Idiopathic Short Stature Era: Trends in Insurer Payments and Patient Financial Burden
por: Grimberg, Adda, et al.
Publicado: (2019)

Comparison of Performance of Psychiatrists vs Other Outpatient Physicians in the 2020 US Medicare Merit-Based Incentive Payment System
por: Qi, Andrew C., et al.
Publicado: (2022)

Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
por: Stoll, Marlene, et al.
Publicado: (2022)

Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by Applicants
por: Chahal, Harinder Singh, et al.
Publicado: (2021)

Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists
por: Weng, Julius K., et al.
Publicado: (2019)

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
por: Ozieranski, Piotr, et al.
Publicado: (2019)

Association of Organizational Factors and Physician Practices’ Participation in Alternative Payment Models
por: Ouayogodé, Mariétou H., et al.
Publicado: (2020)

Changes in Industry Marketing and Research Payments to US Physicians and Teaching Hospitals During the COVID-19 Pandemic
por: Uppal, Nishant, et al.
Publicado: (2022)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Trends in Dialysis Industry Consolidation After Medicare Payment Reform, 2006-2016
por: Sloan, Caroline E., et al.
Publicado: (2021)

Performance of Physician Groups and Hospitals Participating in Bundled Payments Among Medicare Beneficiaries
por: Liao, Joshua M., et al.
Publicado: (2022)

Examination of Potential Industry Conflicts of Interest and Disclosures by Contributors to Online Medical Resource Databases
por: VanDeMark, SooYoung H., et al.
Publicado: (2022)

Financial Disclosures Reported by Industry Among Authors of the American Academy of Ophthalmology Clinical Practice Guidelines
por: Nguyen, Anne Xuan-Lan, et al.
Publicado: (2023)

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
por: Fabbri, Alice, et al.
Publicado: (2018)

The Attitudes of Physicians and the General Public toward Prognostic Disclosure of Different Serious Illnesses: a Korean Nationwide Study
por: Oh, Si Nae, et al.
Publicado: (2020)

Association of the Implementation of Child Tax Credit Advance Payments With Food Insufficiency in US Households
por: Shafer, Paul R., et al.
Publicado: (2022)

Association of the Expiration of Child Tax Credit Advance Payments With Food Insufficiency in US Households
por: Bovell-Ammon, Allison, et al.
Publicado: (2022)

Association of the 2021 Child Tax Credit Advance Payments With Low Birth Weight in the US
por: Margerison, Claire E., et al.
Publicado: (2023)

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020)

Association of Specialist Physician Payment Model With Visit Frequency, Quality, and Costs of Care for People With Chronic Disease
por: Quinn, Amity E., et al.
Publicado: (2019)

Association of Physician Group Practice Participation in Bundled Payments With Patient Selection, Costs, and Outcomes for Joint Replacement
por: Joynt Maddox, Karen E., et al.
Publicado: (2021)

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study
por: Kim, Min Sun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4kser66benkncnvdo89fcmd78p